Učitavanje...
Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness
Anti-interleukin (IL) therapies have emerged as a major treatment for patients with moderate-to-severe psoriasis. This article reviews the up-to-date results of pivotal clinical trials targeting the interleukins used for the treatment of psoriasis, including IL-1, IL-2, IL-6, IL-8, IL-10, IL-12, IL-...
Spremljeno u:
| Izdano u: | Ther Adv Musculoskelet Dis |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5764033/ https://ncbi.nlm.nih.gov/pubmed/29344110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X17735756 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|